ArticleJournal of clinical psychopharmacology

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder.

Mary Hobart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.